BridgeMD
Compares treatment options for Hemiplegic Cerebral Palsy
Official title Modified Constraint Induced Movement Therapy Versus Virtual Reality Training in Children With Cerebral Palsy
ClinicalTrials.gov ID: NCT06846190
What this study is testing
- What it's testing
- Children with hemiplegic cerebral palsy (CP) are characterized by motor impairments mainly lateralized to one side of the body, with greater upper limb than lower limb involvement; these impairments may further limit the daily activities and school participation of children with hemiplegic CP. For the improvement of activity limitations in hemipelagic cerebral palsy children will take 20 hemiplegic cerebral palsy children with the age of 5-16 year all participants will be randomly assign and use modified Constraint induced movement therapy and virtual reality techniques.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 12
You may be able to join if
- Age range between 5 to 16 years of age.
- Medical diagnosis of spastic hemiparetic CP.
- At least 20◦wrist and 10◦ active finger extension from full flexion.
- More movement deficits in 1 upper extremity (less than 2.5 on the Amount of Use scale (AOU) on the Pediatric Motor Activity Log (PMAL)).
- Muscle tone less than 3 on the Modified Ashworth Scale.
You likely can't join if
- Health problems not associated with CP.
- Seizure hemispatial neglect.
- Orthopaedic surgery on the involved upper extremity.
- Botulinum toxin therapy for the affected upper extremity within the past 6 months or within the study period.
- Balance problems
See the full eligibility criteria
- Age range between 5 to 16 years of age.
- Medical diagnosis of spastic hemiparetic CP.
- At least 20◦wrist and 10◦ active finger extension from full flexion.
- More movement deficits in 1 upper extremity (less than 2.5 on the Amount of Use scale (AOU) on the Pediatric Motor Activity Log (PMAL)).
- Muscle tone less than 3 on the Modified Ashworth Scale.
- Normal or corrected-to-normal vision and hearing.
- Classified level I, II, or III of the Manual Ability Classification System ( MACS) for Children with CP
- Health problems not associated with CP.
- Seizure hemispatial neglect.
- Orthopaedic surgery on the involved upper extremity.
- Botulinum toxin therapy for the affected upper extremity within the past 6 months or within the study period.
- Balance problems
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.